Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns
N. Engl. J. Med 2022 Jul 14;387(2)148-159, YW Wu, BA Comstock, FF Gonzalez, DE Mayock, AM Goodman, NL Maitre, T Chang, KP Van Meurs, AL Lampland, E Bendel-Stenzel, AM Mathur, TW Wu, D Riley, U Mietzsch, L Chalak, J Flibotte, JH Weitkamp, KA Ahmad, TD Yanowitz, M Baserga, BB Poindexter, EE Rogers, JR Lowe, KCK Kuban, TM O'Shea, JL Wisnowski, RC McKinstry, S Bluml, S Bonifacio, KL Benninger, R Rao, CD Smyser, GM Sokol, S Merhar, MD Schreiber, HC Glass, PJ Heagerty, SE JuulFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.